329 related articles for article (PubMed ID: 35326404)
1. MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of G
Wang Z; Franke K; Bal G; Li Z; Zuberbier T; Babina M
Cells; 2022 Mar; 11(6):. PubMed ID: 35326404
[TBL] [Abstract][Full Text] [Related]
2. Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by FcεRI Aggregation but with Similar Dependence on the Extracellular Signal-Regulated Kinase 1/2 Module in Human Skin Mast Cells.
Wang Z; Franke K; Zuberbier T; Babina M
J Invest Dermatol; 2022 Feb; 142(2):414-424.e8. PubMed ID: 34329659
[TBL] [Abstract][Full Text] [Related]
3. Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK.
Babina M; Wang Z; Franke K; Zuberbier T
Cells; 2021 Jan; 10(1):. PubMed ID: 33429916
[TBL] [Abstract][Full Text] [Related]
4. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.
Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M
Cells; 2019 Apr; 8(4):. PubMed ID: 30979016
[TBL] [Abstract][Full Text] [Related]
5. Synergism between IL-33 and MRGPRX2/FcεRI Is Primarily Due to the Complementation of Signaling Modules, and Only Modestly Supplemented by Prolonged Activation of Selected Kinases.
Franke K; Li Z; Bal G; Zuberbier T; Babina M
Cells; 2023 Nov; 12(23):. PubMed ID: 38067128
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
[TBL] [Abstract][Full Text] [Related]
7. MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture.
Babina M; Wang Z; Artuc M; Guhl S; Zuberbier T
Exp Dermatol; 2018 Nov; 27(11):1298-1303. PubMed ID: 30091263
[TBL] [Abstract][Full Text] [Related]
8. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events.
Baldo BA
Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437
[TBL] [Abstract][Full Text] [Related]
9. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2.
Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA
Front Immunol; 2021; 12():625284. PubMed ID: 33790895
[TBL] [Abstract][Full Text] [Related]
10. β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells.
Wang Z; Li Z; Bal G; Franke K; Zuberbier T; Babina M
Front Allergy; 2022; 3():930233. PubMed ID: 35910860
[TBL] [Abstract][Full Text] [Related]
11. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
Thapaliya M; Ali H
Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
[TBL] [Abstract][Full Text] [Related]
12. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
[TBL] [Abstract][Full Text] [Related]
13. MrgprX2 regulates mast cell degranulation through PI3K/AKT and PLCγ signaling in pseudo-allergic reactions.
Zhang F; Hong F; Wang L; Fu R; Qi J; Yu B
Int Immunopharmacol; 2022 Jan; 102():108389. PubMed ID: 34920312
[TBL] [Abstract][Full Text] [Related]
14. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
[TBL] [Abstract][Full Text] [Related]
15. Allergic FcεRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF.
Babina M; Guhl S; Artuc M; Zuberbier T
Allergy; 2018 Jan; 73(1):256-260. PubMed ID: 28859248
[TBL] [Abstract][Full Text] [Related]
16. Authentic and Ectopically Expressed MRGPRX2 Elicit Similar Mechanisms to Stimulate Degranulation of Mast Cells.
Lazki-Hagenbach P; Ali H; Sagi-Eisenberg R
Cells; 2021 Feb; 10(2):. PubMed ID: 33673037
[TBL] [Abstract][Full Text] [Related]
17. MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway.
Babina M; Wang Z; Roy S; Guhl S; Franke K; Artuc M; Ali H; Zuberbier T
J Invest Dermatol; 2021 May; 141(5):1286-1296.e4. PubMed ID: 33058860
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
Adhikari N; Shim WS
Arch Pharm Res; 2022 Sep; 45(9):644-657. PubMed ID: 36183260
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells.
Chaki S; Alkanfari I; Roy S; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2021; 12():803335. PubMed ID: 35126366
[TBL] [Abstract][Full Text] [Related]
20. Activation of ryanodine-sensitive calcium store drives pseudo-allergic dermatitis
Wang Z; Zhao X; Zhou H; Che D; Du X; Ye D; Zeng W; Geng S
Front Immunol; 2023; 14():1207249. PubMed ID: 37404822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
